Biliary Stents Market by Product (Biliary Metal Stents and Biliary Plastic Stents) and by End Users (Hospitals, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Report Number: 3584
  • Publish Date: 24-May-2018

Reports Overview

Biliary stents are small mesh-like tubes, which do not contain any coating or covering. Stents are inserted into the liver to treat hepatic blockage and obstructive hepatic diseases, such as jaundice, cholecystitis, hepato-biliary diseases, and cholangitis. Biliary stents are utilized to treat obstruction present in the bile duct.

Factors such as increase in demand for minimally invasive techniques, technological advancements, and rise in geriatric populations drive the market growth. In addition, increase in awareness of the population and rise in demand for bioresorbable stents fuel the market growth. However, factors such as post-operative complications and stringent government regulations for approval are expected to restrain the market growth. Moreover, R&D in the field of surgical equipment is anticipated to create new opportunities during the forecast period.

Biliary stents market is segmented on the basis of product, end user, and geography. Based on product, the market is bifurcated into biliary metal stents and biliary plastic stents. By end user, the market is classified into as hospitals, ambulatory surgical centers, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report offers a quantitative analysis to assist the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments facilitates to determine various products available in the market.
  • Key players are profiled and their strategies are analyzed thoroughly to predict the competitive market outlook.

Biliary Stents Market Key Segments:

By Product

  • Biliary Metal Stents
  • Biliary Plastic Stents

By End-user

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

List of players profiled in the report

  • Abbott Laboratories
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical
  • B. Braun Melsungen AG
  • Medtronic
  • Terumo Corporation
  • Endotech
  • Biotronik SE & Co. KG
  • Biosensors International Group, Ltd

Table Of Content

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 BILIARY STENTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BILIARY METAL STENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. BILIARY PLASTIC STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 BILIARY STENTS MARKET, BY END-USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS

5.3.1. Market size and forecast

5.4. OTHERS

5.4.1. Market size and forecast

Chapter: 6 BILIARY STENTS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Biliary Stents Market by Product
6.2.5. North America Biliary Stents Market by End-User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. UK market size and forecast
6.3.3.2. Germany market size and forecast
6.3.3.3. France market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Italy market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Biliary Stents Market by Product
6.3.5. Europe Biliary Stents Market by End-User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. China market size and forecast
6.4.3.2. Japan market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Biliary Stents Market by Product
6.4.5. Asia-Pacific Biliary Stents Market by End-User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Latin America market size and forecast
6.5.3.2. The Middle East market size and forecast
6.5.3.3. Africa market size and forecast

6.5.4. LAMEA Biliary Stents Market by Product
6.5.5. LAMEA Biliary Stents Market by End-User

Chapter: 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. BOSTON SCIENTIFIC CORPORATION

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. CONMED CORPORATION

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. COOK MEDICAL

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. B. BRAUN MELSUNGEN AG

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. MEDTRONIC

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. TERUMO CORPORATION

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. ENDOTECH

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. BIOTRONIK SE & CO. KG

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. BIOSENSORS INTERNATIONAL GROUP, LTD

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

There are no reviews yet.

Be the first to review “Biliary Stents Market Research Report 2018”